Luminex logo

LMNX - Luminex News Story

$36.91 0.0  0.1%

Last Trade - 9:00pm

Sector
Healthcare
Size
Mid Cap
Market Cap £1.23bn
Enterprise Value £1.15bn
Revenue £300.2m
Position in Universe 2379th / 6849

BRIEF-Luminex Submits Joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA for Emergency Use Authorization

Wed 10th March, 2021 11:42am
March 10 (Reuters) - Luminex Corp  LMNX.O :
    * LUMINEX SUBMITS JOINT SARS-COV-2 AND FLU/RSV RESPIRATORY
PANEL
TO FDA FOR EMERGENCY USE AUTHORIZATION

Source text for Eikon:  ID:nPn3lKdc0a 
Further company coverage:  LMNX.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.